Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Carol Burke, MD, completed medical school at the Ohio State University College of Medicine and Public Health, and residency at Riverside Methodist Hospital, both in Columbus, Ohio. Dr. Burke performed her Gastroenterology Fellowship at the Cleveland Clinic in 1993 and has been on the professional staff since that time.
Dr. Burke enjoys patient care, medical education and research, particularly in the area of colorectal polyp and cancer prevention. She is internationally known for her work in the polyposis syndromes and is the Director of the Center for colon polyp and cancer prevention and has been awarded research grants from the National Cancer Institute, American College of Gastroenterology, and Industry to name a few, to study the effects of chemopreventive agents on the prevention of intestinal neoplasia.
She is the co-director of the multi-disciplinary Hereditary Cancer Clinic and provides consultations including risk assessment, and endoscopic evaluation and treatment for individuals with a hereditary predisposition to cancer.
She is the author of numerous peer reviewed manuscripts, abstracts, book chapters, and is a frequent reviewer for many digestive disease journals.
She has served as a committee member, or chairperson in the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy and is currently on the Board of Trustees for the American College of Gastroenterology.
chemoprevention of colorectal neoplasia, colonic neoplasia, colorectal cancer screening strategies, hereditary polyposis and nonpolyposis colorectal cancer, Colon cancer prevention, colon cancer screening, Colonoscopy
Awards & Honors
Dr. Burke is on the Board of Trustees of the American College of Gastroenterology.
Dr. Burke is a member of the National Medical Honor Society, Alpha Omega Alpha
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/13/2015, Dr. Burke has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.